Supplementary Table S11 from AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: A Phase I Trial in Patients with Advanced Solid Tumors

作者：Lillian L. Siu, Sophie Postel‐Vinay, Rafael Villanueva-Vázquez, Guillermo de Velasco, Eduardo Castañón Álvarez, Christos E. Kyriakopoulos, Melissa L. Johnson, Kaïssa Ouali, Stephen McMorn, Helen K. Angell, Felicia Ng, Shashank Saran, Mahdiye Bayat, Teresa Collins, Archana Roy, Arthur W. Lambert, Song Cho, Neil R. Miller, Michele Petruzzelli, John Stone, Christophe Massard · 年份：2026 · DOI：10.1158/1078-0432.32712577 · 研究领域：Cytokine Signaling Pathways and Interactions、T-cell and B-cell Immunology、Immune Cell Function and Interaction

Pharmacokinetic data